KEAP1 and lung carcinoma: A recent study found that upregulation of FSP1 expression via NRF2 in KEAP1-deficient lung cancer cells leads to ferroptosis resistance and radiotherapy resistance, thus identifying an effective therapeutic strategy of targeting CoQ-FSP1 signaling to weaken ferroptosis defenses and overcome radiotherapy resistance caused by KEAP1 inactivation [255].